Aries Wealth Management Astrazeneca PLC Transaction History

Aries Wealth Management

$359 Million
Q3 2024

A detailed history of Aries Wealth Management transactions in Astrazeneca PLC stock. As of the latest transaction made, Aries Wealth Management holds 9,578 shares of AZN stock, worth $625,922. This represents 0.21% of its overall portfolio holdings.

Number of Shares

9,578

Previous 10,470 8.52%

Holding current value

$625,922

Previous $816,000 8.58%

% of portfolio

0.21%

Previous 0.26%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$76.67 - $87.62 $68,389 - $78,157	-892 Reduced 8.52%	9,578 $746,000
Q4 2023 Jan 10, 2024	SELL	$61.89 - $69.28 $557 - $623	-9 Reduced 0.09%	10,470 $705,000
Q3 2023 Oct 19, 2023	BUY	$64.85 - $71.7 $41,050 - $45,386	633 Added 6.43%	10,479 $709,000
Q3 2022 Nov 02, 2022	SELL	$53.02 - $135.75 $9,755 - $24,978	-184 Reduced 1.83%	9,846 $579,000
Q2 2022 Jul 27, 2022	BUY	$59.26 - $71.14 $594,377 - $713,534	10,030 New	10,030 $663,000
Q1 2022 Apr 25, 2022	SELL	$55.72 - $67.12 $558,871 - $673,213	-10,030 Closed	0 $0
Q4 2021 Jun 06, 2022	SELL	$54.02 - $63.83 $1.08 Million - $1.28 Million	-20,060 Reduced 66.67%	10,030 $584,000
Q4 2021 Jan 18, 2022	BUY	$54.02 - $63.83 $1.01 Million - $1.19 Million	18,619 Added 162.31%	30,090 $1.75 Million
Q3 2021 Oct 13, 2021	BUY	$55.56 - $60.79 $23,946 - $26,200	431 Added 3.9%	11,471 $689,000
Q2 2021 Jul 14, 2021	SELL	$48.42 - $60.18 $31,715 - $39,417	-655 Reduced 5.6%	11,040 $661,000
Q1 2021 Apr 20, 2021	BUY	$47.16 - $54.44 $78,521 - $90,642	1,665 Added 16.6%	11,695 $583,000
Q4 2017 Feb 05, 2018	BUY	$32.09 - $34.78 $321,862 - $348,843	10,030	10,030 $355,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aries Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Aries Wealth Management with notifications on news.

Account

Aries Wealth Management Astrazeneca PLC Transaction History